Dual mania represents a distinct and not infrequent subgroup of patients with mania. The exclusion of patients with comorbid substance problems from clinical trials creates a gap in our knowledge on treatment effectiveness.
H. Andreu Gracia, Anna Giménez‐Palomo, Luis Olivier, Iñaki Ochandiano, Òscar de Juan, Tabatha Fernández‐Plaza, S. Salmerón, Lluc Colomer, Eduard Vieta, Isabella Pacchiarotti
Discussion(0)
No comments yet. Be the first to comment.